TipRanks on MSN

Crispr Therapeutics announces Phase 1 data for CTX310

CRISPR Therapeutics (CRSP) announced positive Phase 1 data from its ongoing clinical trial evaluating CTX310, an investigational, in vivo ...

Intellia Therapeutics Presents Positive Pooled Phase 1/2 Data of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema

(GLOBE NEWSWIRE) -- (NASDAQ: NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today presented positive clinical data from a pooled ...